Skip to main content
. 2018 Jan 17;77(5):690–698. doi: 10.1136/annrheumdis-2017-211568

Figure 2.

Figure 2

Proportion of patients achieving a GEI of 0* through week 52. All data shown are as observed among patients as randomised at baseline, receiving at least one dose of apremilast and having pre-existing enthesopathy at baseline (eg, GEI score >0, n=102). GEI, Gladman Enthesitis Index; n/m, number of responders/number of patients with sufficient data for evaluation.